ClinConnect ClinConnect Logo
Search / Trial NCT05266690

Effect of Degree of Polymerization and Linkage of α-glucans on Post-prandial Glucose Response

Launched by SOCIÉTÉ DES PRODUITS NESTLÉ (SPN) · Mar 3, 2022

Trial Information

Current as of June 16, 2025

Completed

Keywords

Postprandial Glucose Response α Glucans Polymerization Decentralized Study Design

ClinConnect Summary

The aim of the present research project is to generate comparative data on post-prandial glucose response (PPGR) of α-glucans varying systematically degree of polymerization and linkage type. These data are expected to contribute to the sugar replacement strategy in food industry.

An additional goal of the study is to demonstrate the feasibility of running a PPGR study remotely, i.e. with the participants carrying out most of the procedures at home.

Remote clinical trials (so called "virtual") have recently started to be implemented in pharmaceutical clinical research with the intent to r...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and female participant
  • Healthy status (based on anamnesis)
  • Age between 18 and 45 years
  • BMI between 18.5 and 29.9 kg/m2
  • Able to understand and sign an informed consent form
  • Able to respect the study procedures and timelines
  • Swiss resident living in canton Fribourg (French part), Neuchâtel, Vaud and Valais which is in the competence of Ethical Committee of Vaud
  • Having wireless internet access at home
  • Exclusion Criteria:
  • Any known metabolic disease including diabetes or drug chronic intake (aspirin, vitamin C and mineral supplements, steroids, protease inhibitors, antidepressants, anxiolytic, or antipsychotics...) possibly impacting (to the opinion of the medical responsible): The digestion or absorption of nutrients, the postprandial glucose response
  • Major medical/surgical event requiring hospitalization in the last 3 months
  • Pregnancy or lactation
  • Known food allergy and intolerance
  • Medically known cutaneous hypersensitivity to adhesives, silicon watch-strap and plasters
  • Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer.
  • Smokers
  • Participant having a hierarchical link with the research team members

About Société Des Produits Nestlé (Spn)

Société des Produits Nestlé (SPN) is a global leader in nutrition, health, and wellness, dedicated to advancing scientific research and innovation in the food and beverage sector. As a subsidiary of Nestlé S.A., SPN focuses on developing high-quality products that promote healthier lifestyles and improve overall well-being. The organization actively sponsors clinical trials to evaluate the efficacy and safety of its nutritional offerings, collaborating with healthcare professionals and research institutions to gather valuable insights that inform product development and public health initiatives. Through its commitment to evidence-based research, SPN aims to enhance consumer trust and contribute to the advancement of nutritional science.

Locations

Lausanne, Vaud, Switzerland

Patients applied

0 patients applied

Trial Officials

Pamela Sun, MD

Principal Investigator

Nestlé Research - Clinical Research Unit - Clinical Innovation Lab

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials